Rebekah J Nevel1, Errine T Garnett2, John A Worrell3, Ronald L Morton4, Lawrence M Nogee5, Timothy S Blackwell2, Lisa R Young1,2. 1. 1 Division of Pulmonary Medicine, Department of Pediatrics. 2. 2 Division of Allergy, Pulmonary, and Critical Care, Department of Medicine, and. 3. 3 Department of Radiology and Radiological Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee. 4. 4 Division of Pulmonary Medicine, University of Louisville, Louisville, Kentucky; and. 5. 5 Eudowood Neonatal Pulmonary Division, Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland.
Abstract
RATIONALE: Neuroendocrine cell hyperplasia of infancy (NEHI) is a diffuse lung disease that presents in infancy and improves during childhood. Long-term outcomes have not previously been described. In one familial cohort, we have reported that NEHI is associated with a heterozygous variant of NKX2.1/TTF1. OBJECTIVES: Our objective was to determine whether pulmonary abnormalities persist in adults with NEHI, to aid in elucidating the natural history of this disease. METHODS: Four adult relatives with heterozygous NKX2.1 mutation and with clinical histories compatible with NEHI enrolled in a prospective study that included questionnaires, pulmonary function tests, and chest computed tomography scans. MEASUREMENTS AND MAIN RESULTS: Mild radiologic abnormalities including mosaicism were seen in all four cases. Three individuals had obstruction on pulmonary function tests, two had marked air trapping, and three had symptomatic impairments with exercise intolerance. CONCLUSIONS: Although clinical improvement occurs over time, NEHI may result in lifelong pulmonary abnormalities in some cases. Further studies are required to better describe the natural history of this disease and would be facilitated by additional delineation of genetic mechanisms to enable improved case identification.
RATIONALE: Neuroendocrine cell hyperplasia of infancy (NEHI) is a diffuse lung disease that presents in infancy and improves during childhood. Long-term outcomes have not previously been described. In one familial cohort, we have reported that NEHI is associated with a heterozygous variant of NKX2.1/TTF1. OBJECTIVES: Our objective was to determine whether pulmonary abnormalities persist in adults with NEHI, to aid in elucidating the natural history of this disease. METHODS: Four adult relatives with heterozygous NKX2.1 mutation and with clinical histories compatible with NEHI enrolled in a prospective study that included questionnaires, pulmonary function tests, and chest computed tomography scans. MEASUREMENTS AND MAIN RESULTS: Mild radiologic abnormalities including mosaicism were seen in all four cases. Three individuals had obstruction on pulmonary function tests, two had marked air trapping, and three had symptomatic impairments with exercise intolerance. CONCLUSIONS: Although clinical improvement occurs over time, NEHI may result in lifelong pulmonary abnormalities in some cases. Further studies are required to better describe the natural history of this disease and would be facilitated by additional delineation of genetic mechanisms to enable improved case identification.
Authors: Gwendolyn S Kerby; Brandie D Wagner; Jonathan Popler; Thomas C Hay; Carol Kopecky; Stephanie L Wilcox; Ralph R Quinones; Roger H Giller; Frank J Accurso; Robin R Deterding Journal: Pediatr Pulmonol Date: 2012-11-20
Authors: Heikki Lukkarinen; Anna Pelkonen; Jouko Lohi; Kristiina Malmström; L Pekka Malmberg; Merja Kajosaari; Harri Lindahl; Anna Föhr; Olli Ruuskanen; Mika J Mäkelä Journal: Arch Dis Child Date: 2012-11-17 Impact factor: 3.791
Authors: Alan S Brody; R Paul Guillerman; Thomas C Hay; Brandie D Wagner; Lisa R Young; Gail H Deutsch; Leland L Fan; Robin R Deterding Journal: AJR Am J Roentgenol Date: 2010-01 Impact factor: 3.959
Authors: Laurie L Carr; Jonathan H Chung; Rosane Duarte Achcar; Zoran Lesic; Ji Y Rho; Kunihiro Yagihashi; Robert M Tate; Jeffrey J Swigris; Jeffrey A Kern Journal: Chest Date: 2015-02 Impact factor: 9.410
Authors: Lisa R Young; Alan S Brody; Thomas H Inge; James D Acton; Ronald E Bokulic; Claire Langston; Gail H Deutsch Journal: Chest Date: 2010-09-30 Impact factor: 9.410
Authors: Adrienne A Nassar; Dawn E Jaroszewski; Richard A Helmers; Thomas V Colby; Bhavesh M Patel; Farouk Mookadam Journal: Am J Respir Crit Care Med Date: 2011-03-25 Impact factor: 21.405
Authors: Rola Abou Taam; Francis Jaubert; Sophie Emond; Muriel Le Bourgeois; Ralph Epaud; Chantal Karila; Delphine Feldmann; Pierre Scheinmann; Jacques de Blic Journal: Pediatr Pulmonol Date: 2009-02
Authors: Itishri Sahu; A K M Ashiqul Haque; Brian Weidensee; Petra Weinmann; Michael S D Kormann Journal: Mol Ther Date: 2019-03-06 Impact factor: 11.454
Authors: Marco Volante; Ozgur Mete; Giuseppe Pelosi; Anja C Roden; Ernst Jan M Speel; Silvia Uccella Journal: Endocr Pathol Date: 2021-02-27 Impact factor: 3.943
Authors: Chetna Mangat; Mikaela DeCoster; Natasa Milosavljevic; Lisa Hiskey; Elizabeth H Ristagno; Nadir Demirel Journal: Case Rep Pediatr Date: 2022-08-12